Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600866.SS

HOLDREMOVE

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong · Healthcare · China · $1.2B · Avg Vol: $18M/d

46
StockRank
Q
38
V
63
M
37
P/E (TTM)
17.0x
ROE
5.3%
D/E
0.7x
Dividend %
8.0%
AI CONVICTION THESIS

Star Lake Bioscience is primarily a commodity chemical and amino acid producer, lacking the high-barrier regulatory moats and pricing power of a true CDMO compounder.

COMPANY DESCRIPTION

Star Lake Bioscience specializes in the research, development, and manufacture of biochemical drugs, food additives, and feed additives, with a focus on amino acids and nucleoside regulators. The company maintains a strong market position through its vertically integrated production of L-lysine and L-threonine, leveraging advanced fermentation technologies. It serves as a key supplier to both domestic and international agricultural and pharmaceutical sectors.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue2.6B2.6B2.6B2.3B-3.1%
EPS0.080.060.080.094.8%
Shares1.7B1.7B1.7B1.7B0.0%
Debt663M622M509M922M11.7%
Equity1.0B1.1B1.2B1.2B6.1%
Op CF246M299M354M191M-8.1%
Inv CF-117M-127M-128M-356M
Fin CF-90M-104M-251M192M
Loading...
PRICE (1M)-18.0%
0.680.750.810.870.93Apr 30May 26Jun 15
SMA 50SMA 200
Close
$0.70
RSI (14)
28.6
52W High
$1.26
From 52W High
0.6%

SCORE BREAKDOWN

Quality
38
ROIC
11.7%78.2
ROE
5.3%57.3
GP/Assets
11.2%28.3
Op. Margin
-1.1%34.3
FCF/Assets
-16.0%21.0
Piotroski
28.8
Int. Cover
16.1x71.5
D/E Ratio
0.73x21.2
Current Ratio
0.97x9.3
Value
63
P/E (TTM)
17.0x66.4
EV/EBITDA
9.7x43.0
P/FCF
N/A
P/B
1.0x79.8
P/S
0.5x92.6
Div Yield
8.0%97.7
Momentum
37
52W High %
56%32.0
RS 6M
-39%31.0
SMA 50/200
0.84x20.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
83.5
Q Growth
N/A

FUNDAMENTALS

Market Cap
$1.2B
P/E (Forward)
6.6x
Gross Margin
12.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600866.SS are excluded.

TickerCompanyMkt CapStockRankSignal
600866.SSStar Lake Bioscience Co., Inc.Zhaoqing Guangdong(you)$1.2B46HOLD
688366.SSShanghai Haohai Biological Technology Co., Ltd.$1.1B48HOLD
603229.SSZhejiang Ausun Pharmaceutical Co., Ltd.$1.2B43HOLD
300497.SZJiangxi Fushine Pharmaceutical Co., Ltd.$1.2B41HOLD
688739.SSLiaoning Chengda Biotechnology Co.,Ltd.$1.3B42HOLD
301207.SZHualan Biological Vaccine Inc.$1.6B47HOLD
688202.SSShanghai Medicilon Inc.$1.2B53HOLD
688658.SSYoucare Pharmaceutical Group Co., Ltd.$1.2B39HOLD
688222.SSHitGen Inc.$1.8B47HOLD
2171.HKCARsgen Therapeutics Holdings Limited$1.3B39HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) — Stock Score Summary

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) has a MoatMap StockRank of 46/100 based on Quality (38/100), Value (63/100), and Momentum (37/100) factor scores. The current signal is HOLD. Star Lake Bioscience is primarily a commodity chemical and amino acid producer, lacking the high-barrier regulatory moats and pricing power of a true CDMO compounder.

Star Lake Bioscience specializes in the research, development, and manufacture of biochemical drugs, food additives, and feed additives, with a focus on amino acids and nucleoside regulators. The company maintains a strong market position through its vertically integrated production of L-lysine and L-threonine, leveraging advanced fermentation technologies. It serves as a key supplier to both domestic and international agricultural and pharmaceutical sectors.

Key Financial Metrics

Price$0.70
Market Cap$1.2B
P/E (TTM)17.00
P/E (Forward)6.61
Price/Book0.97
Return on Equity5.3%
Return on Invested Capital11.7%
Debt/Equity72.93
Gross Margin12.4%
Operating Margin-1.1%
Revenue Growth-7.4%
Dividend Yield8.0%
Free Cash Flow$-60M

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Star Lake Bioscience Co., Inc.Zhaoqing Guangdong’s (600866.SS) StockRank?
MoatMap’s StockRank for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) is 46/100, with a Hold signal. It is a composite of Quality (38), Value (63), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Star Lake Bioscience Co., Inc.Zhaoqing Guangdong have an economic moat?
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Star Lake Bioscience Co., Inc.Zhaoqing Guangdong a buy, hold, or sell?
MoatMap’s current signal for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) is Hold, based on a StockRank of 46/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Star Lake Bioscience Co., Inc.Zhaoqing Guangdong in?
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).